Life Science Company News

Reset
Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Kymera Therapeutics Inc.

Sotera Health Reports First-Quarter 2024 Results

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Sotera Health

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Shattuck Labs, Inc.

Alvotech Announces Participation at BofA Securities Healthcare Conference 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Alvotech

Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Ocugen, Inc.

Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Arbutus Biopharma Corporation

BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  BridgeBio Pharma, Inc.

Guangzhou Bio-gene Technologies Announces Initiation of Phase I Clinical Trial for BG1805, a CAR-T Targeting CLL-1

Read more ››
By: GlobeNewswire - 02 May 2024

Context Therapeutics Announces $100 Million Private Placement

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Context Therapeutics Inc.

Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Arbutus Biopharma Corporation

Quipt Home Medical Announces Normal Course Issuer Bid

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Quipt Home Medical, Corp.

VitalHub Announces Q1 2024 Conference Call Date

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  VitalHub Corp

Biogen Reports Progress on Corporate Responsibility Priorities

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Biogen Inc.

Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Theratechnologies Inc.

Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Altimmune, Inc. | Analytica Ltd

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Intellia Therapeutics, Inc.

Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Anavex Life Sciences Corp.

Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Context Therapeutics Inc.

BioPorto A/S to Host First Quarter 2024 Earnings Webcast and Investor Meeting

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  BioPorto Diagnostics A/S

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  60° Pharmaceuticals, LLC
Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »